PROK short interest
ProKidney Corp. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 23,785,320 |
|---|---|
| Change vs prior report | 2,339,954 (+10.9%) |
| Change over six months | +42.6% |
| Days to cover | 10.97 (sector: 3.78) |
| Average daily volume | 2,167,549 |
| Rank in Healthcare | #91 of 922 by days to cover |
PROK short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 23,785,320 | +10.9% | 10.97 | 2,167,549 |
| 2026-09-15 | 21,445,366 | +3.4% | 19.04 | 1,126,265 |
| 2026-08-31 | 20,737,263 | -3.5% | 17.69 | 1,172,348 |
| 2026-08-14 | 21,494,435 | +3.8% | 18.74 | 1,147,132 |
| 2026-07-31 | 20,706,315 | -1.0% | 22.41 | 924,016 |
| 2026-07-15 | 20,913,200 | +7.7% | 15.83 | 1,321,416 |
| 2026-06-30 | 19,425,505 | +10.7% | 10.00 | 1,943,294 |
| 2026-06-15 | 17,547,522 | -2.7% | 17.87 | 982,147 |
| 2026-05-29 | 18,032,397 | -6.3% | 18.45 | 977,251 |
| 2026-05-15 | 19,241,878 | +5.4% | 25.22 | 762,948 |
| 2026-04-30 | 18,263,285 | +3.8% | 27.47 | 664,916 |
| 2026-04-15 | 17,600,654 | +5.5% | 12.81 | 1,374,164 |
| 2026-03-31 | 16,683,004 | +8.8% | 18.17 | 918,231 |
| 2026-03-13 | 15,332,082 | -1.5% | 25.16 | 609,305 |
| 2026-02-27 | 15,565,337 | -4.0% | 37.44 | 415,744 |
| 2026-02-13 | 16,205,625 | +3.8% | 16.20 | 1,000,564 |
| 2026-01-30 | 15,610,003 | +2.4% | 15.22 | 1,025,542 |
| 2026-01-15 | 15,251,796 | +0.5% | 14.27 | 1,068,622 |
| 2025-12-31 | 15,182,669 | +9.9% | 11.38 | 1,334,634 |
| 2025-12-15 | 13,812,601 | -6.6% | 12.16 | 1,135,517 |
| 2025-11-28 | 14,786,117 | +5.9% | 11.95 | 1,237,126 |
| 2025-11-14 | 13,964,229 | +13.6% | 7.76 | 1,800,339 |
| 2025-10-31 | 12,294,628 | +14.5% | 8.50 | 1,446,465 |
| 2025-10-15 | 10,736,252 | +0.3% | 3.78 | 2,843,259 |
| 2025-09-30 | 10,707,361 | +5.8% | 8.42 | 1,271,003 |
import finzdata as yf
yf.Ticker("PROK").short_interest # every report since 2017
yf.Client().short_interest(["PROK"], start="2018-01-01")Healthcare short interest · PROK price history · Who owns PROK · All short interest